Roche Fined $14M for Undermining Biosimilar and Generic Competition in Romania

Published date07 February 2020
Subject MatterPrescription Drugs,Biosimilars,Generic Drugs,Ministry of Health,Anti-Competitive,Romania,Antitrust Violations,Pharmaceutical Industry
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT